Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

New Head of Federal Office Clear on Protecting Human Research Participants

Article Abstract:

The new director of the Office of Human Research Protection met with other scientists to discuss financial conflicts of interest in medical research. The meeting was called after it was discovered that a researcher participating in a gene therapy trial that killed Jesse Gelsinger owned stock in the company that sponsored the trial.

Author: Marwick, Charles
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
Conflict of interests (Agency), Conflicts of interest (Agency)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bioethics advisory commission holds first meeting to define governing principles of ethical research

Article Abstract:

The National Bioethics Advisory Commission met in Oct 1996, one year after it was created by Pres Clinton. Its two major mandates are to review current procedures covering humans who are used as subjects in medical research and the ethical aspects of genetic testing. An additional topic of discussion will be the deficiencies in the institutional review board (IRB) system. Policies are needed to cover research on those who cannot give informed consent, such as children or the mentally ill. Laws and regulations cannot replace a responsible attitude among researchers.

Author: Marwick, Charles
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
Bioethics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Assessment of exception to informed consent

Article Abstract:

The FDA held a meeting in 1997 to evaluate the exception to informed consent regulation. This regulation, implemented in 1996, allows medical researchers to treat patients in emergency situations with investigational treatments without getting their immediate consent. This is important because the patient may be unconscious and unable to consent. However, the researchers are required to disseminate information about the study in the community, especially among those most likely to be affected. They must also try to find a family member or relative who can give consent within a reasonable amount of time.

Author: Marwick, Charles
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
Laws, regulations and rules, Informed consent (Medical law), Informed consent

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Conferences, meetings and seminars, Ethical aspects, Human experimentation in medicine, Human medical experimentation, Medical research
Similar abstracts:
  • Abstracts: Antibiotics and Risk of Subsequent First-time Acute Myocardial Infarction. HMG-CoA Reductase Inhibitors and the Risk of Fractures
  • Abstracts: Basal metabolic rate in hyperemesis gravidarum: comparison to normal pregnancy and response to treatment. Plasma adenosine levels increase in women with normal pregnancies
  • Abstracts: Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys
  • Abstracts: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
  • Abstracts: A 25-year-old with asthma cardiac failure, diarrhea, and weakness of the right hand. A 69-year-old woman with pleuritic pain and a pulmonary arterial obstruction
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.